Severe Acute Respiratory Syndrome Due to COVID-19 Among Children and Adolescents in Brazil: Profile of Deaths and Hospital Lethality As at Epidemiological Week 38, 2020

Overview

Journal Epidemiol Serv Saude

Date 2020 Nov 11

PMID 33175011

Citations 16

Authors

Danubia Hillesheim

Yana Tamara Tomasi

Thamara Hubler Figueiro

Karina Mary de Paiva

Affiliations

Soon will be listed here.

Abstract

Objective: To describe the profile of deaths and the lethality of Severe Acute Respiratory Syndrome (SARS) due to COVID-19 in hospitalized children and adolescents in Brazil.

Methods: This was a cross-sectional study conducted with data from the SARS notification forms of children and adolescents (0 to 19 years old) with laboratory-confirmed COVID-19. Notifications with complete progression of SARS due to COVID-19 were included, up to the 38th Epidemiological Week of 2020.

Results: 6,989 hospitalizations were investigated, 661 died, resulting in 9.5% hospital lethality. Higher lethality rates were observed among children under 1 year of age (14.2%), female children and adolescents (9.7%), the indigenous (23.0%), and those living in rural areas (18.1 %), as well as in the Northeast (15.4%) and North (9.7%) regions of Brazil.

Conclusion: Differences in hospital mortality were found according to sociodemographic characteristics and marked regional inequalities.

Citing Articles

Epidemiological profile of patients hospitalized with Crohn's disease due to severe acute respiratory infection during the COVID-19 pandemic: a 2-year report from Brazil.

Nascimento L, Marson F, Dos Santos R Front Med (Lausanne). 2024; 11:1440101.

PMID: 39507710 PMC: 11537927. DOI: 10.3389/fmed.2024.1440101.

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.

Aparicio C, Willis Z, Nakamura M, Wolf J, Little C, Maron G J Pediatric Infect Dis Soc. 2024; 13(7):352-362.

PMID: 38780125 PMC: 11519042. DOI: 10.1093/jpids/piae052.

Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.

Willis Z, Oliveira C, Abzug M, Anosike B, Ardura M, Bio L J Pediatric Infect Dis Soc. 2024; 13(3):159-185.

PMID: 38339996 PMC: 11494238. DOI: 10.1093/jpids/piad116.

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.

Aparicio C, Willis Z, Nakamura M, Wolf J, Little C, Maron G medRxiv. 2024; .

PMID: 38293040 PMC: 10827273. DOI: 10.1101/2024.01.17.24301452.

Severe Acute Respiratory Syndrome (SARS) in the Context of the COVID-19 Pandemic Among Indigenous Peoples of Brazil: Epidemiology and Risk Factors Associated with Death.

Novaes T, Lara D, da Silva S J Racial Ethn Health Disparities. 2023; 11(4):1908-1917.

PMID: 37314690 DOI: 10.1007/s40615-023-01660-z.